brichta l - Search Results

Year	Number of Results
1972	2
2003	1
2005	1
2006	7
2008	1
2010	1
2013	1
2014	1
2015	1
2016	1
2017	2
2018	1
2019	3
2020	4
2021	2
2022	0

1

Selective Neuronal Vulnerability in Alzheimer's Disease: A Network-Based Analysis.

Roussarie JP, Yao V, Rodriguez-Rodriguez P, Oughtred R, Rust J, Plautz Z, Kasturia S, Albornoz C, Wang W, Schmidt EF, Dannenfelser R, Tadych A, Brichta L, Barnea-Cramer A, Heintz N, Hof PR, Heiman M, Dolinski K, Flajolet M, Troyanskaya OG, Greengard P. Roussarie JP, et al. Among authors: brichta l. Neuron. 2020 Sep 9;107(5):821-835.e12. doi: 10.1016/j.neuron.2020.06.010. Epub 2020 Jun 29. Neuron. 2020. PMID: 32603655 Free PMC article.

2

Loss of SATB1 Induces p21-Dependent Cellular Senescence in Post-mitotic Dopaminergic Neurons.

Riessland M, Kolisnyk B, Kim TW, Cheng J, Ni J, Pearson JA, Park EJ, Dam K, Acehan D, Ramos-Espiritu LS, Wang W, Zhang J, Shim JW, Ciceri G, Brichta L, Studer L, Greengard P. Riessland M, et al. Among authors: brichta l. Cell Stem Cell. 2019 Oct 3;25(4):514-530.e8. doi: 10.1016/j.stem.2019.08.013. Epub 2019 Sep 19. Cell Stem Cell. 2019. PMID: 31543366 Free PMC article.

3

Topical Janus kinase inhibitors for the treatment of pediatric alopecia areata.

Bayart CB, DeNiro KL, Brichta L, Craiglow BG, Sidbury R. Bayart CB, et al. Among authors: brichta l. J Am Acad Dermatol. 2017 Jul;77(1):167-170. doi: 10.1016/j.jaad.2017.03.024. J Am Acad Dermatol. 2017. PMID: 28619556 No abstract available.

4

Use of Tofacitinib, 2%, Ointment for Periorbital Discoid Lupus Erythematosus.

Mazori DR, Min MS, Kassamali B, Brichta L, Merola JF, Vleugels RA, LaChance AH. Mazori DR, et al. Among authors: brichta l. JAMA Dermatol. 2021 Jul 1;157(7):880-882. doi: 10.1001/jamadermatol.2021.1198. JAMA Dermatol. 2021. PMID: 34076672 No abstract available.

5

Topical sirolimus: Difference between compounded preparations and commercial oral solution.

Brichta L, Carver JG, Carver DeKlotz CM. Brichta L, et al. Pediatr Dermatol. 2021 Jul;38(4):967-969. doi: 10.1111/pde.14637. Epub 2021 Jun 1. Pediatr Dermatol. 2021. PMID: 34060128

6

Advances in the pharmacological treatment of Parkinson's disease: targeting neurotransmitter systems.

Brichta L, Greengard P, Flajolet M. Brichta L, et al. Trends Neurosci. 2013 Sep;36(9):543-54. doi: 10.1016/j.tins.2013.06.003. Epub 2013 Jul 19. Trends Neurosci. 2013. PMID: 23876424 Review.

7

Spinal muscular atrophy: from gene to therapy.

Wirth B, Brichta L, Hahnen E. Wirth B, et al. Among authors: brichta l. Semin Pediatr Neurol. 2006 Jun;13(2):121-31. doi: 10.1016/j.spen.2006.06.008. Semin Pediatr Neurol. 2006. PMID: 17027862 Review.

8

Molecular determinants of selective dopaminergic vulnerability in Parkinson's disease: an update.

Brichta L, Greengard P. Brichta L, et al. Front Neuroanat. 2014 Dec 15;8:152. doi: 10.3389/fnana.2014.00152. eCollection 2014. Front Neuroanat. 2014. PMID: 25565977 Free PMC article. Review.

9

Dopamine metabolism by a monoamine oxidase mitochondrial shuttle activates the electron transport chain.

Graves SM, Xie Z, Stout KA, Zampese E, Burbulla LF, Shih JC, Kondapalli J, Patriarchi T, Tian L, Brichta L, Greengard P, Krainc D, Schumacker PT, Surmeier DJ. Graves SM, et al. Among authors: brichta l. Nat Neurosci. 2020 Jan;23(1):15-20. doi: 10.1038/s41593-019-0556-3. Epub 2019 Dec 16. Nat Neurosci. 2020. PMID: 31844313 Free PMC article.

10

Ponatinib Combined With Rapamycin Causes Regression of Murine Venous Malformation.

Li X, Cai Y, Goines J, Pastura P, Brichta L, Lane A, Le Cras TD, Boscolo E. Li X, et al. Among authors: brichta l. Arterioscler Thromb Vasc Biol. 2019 Mar;39(3):496-512. doi: 10.1161/ATVBAHA.118.312315. Arterioscler Thromb Vasc Biol. 2019. PMID: 30626204 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results